Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jia-Lian Xu"'
Autor:
Mei Dong, Lu Xianping, Ning Zhiqiang, Haixiang Cao, Jia-Lian Xu, Feng-Yi Feng, Puyuan Xing, Gui-Fang Dou, Zhi-Yun Meng, Yuankai Shi
Publikováno v:
Cancer Chemotherapy and Pharmacology. 69:1413-1422
Chidamide (CS055/HBI-8000) is a new benzamide class of histone deacetylase inhibitor with marked anti-tumor activity. This study reports the phase I results. Patients with advanced solid tumors or lymphomas received oral doses of 5, 10, 17.5, 25, 32.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6acb705ac2fb1b5a1aadf818827653d
https://doi.org/10.1007/s00280-012-1847-5
https://doi.org/10.1007/s00280-012-1847-5
Autor:
Nai-hui, Chu, Li-zhen, Zhu, Zhi-zhong, Yie, Song-lin, Yuan, Jing-yun, Wang, Jia-lian, Xu, Li-ping, Ma
Publikováno v:
Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases. 26(9)
To study and evaluate the efficacy and safety of recombinant human interleukin-2 (IL-2) in the treatment of pulmonary tuberculosis.Two hundred and nine cases with re-treated Mycobacterium tuberculosis-positive pulmonary tuberculosis were randomly div
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::76e5ba09ce4a1392d782f97f468d1014
https://pubmed.ncbi.nlm.nih.gov/14521759
https://pubmed.ncbi.nlm.nih.gov/14521759